• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 42866
Device Problems Mechanical Jam (2983); Appropriate Term/Code Not Available (3191)
Patient Problem Therapeutic Effects, Unexpected (2099)
Event Date 11/21/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported the patient was implanted in (b)(6) 2018.The patient had enlarged ventricles and the valve setting was set to 0.5.Two days after implant, the patient was scanned and it was noticed that overdrainage occurred and the ventricles were constricted.The valve setting was adjusted to 1.5, however the ventricles enlarged once more after the patient was scanned two days later.The valve was adjusted to 1.0 and ventricles constricted again.A second doctor was called in to identify the cause of the underdrainage and overdrainage.The doctor noted that upon adjustment, the new adjusted pressure setting did not reflect the change, rather it still displayed the older setting.As the patient¿s condition was deteriorating, the doctor replaced the valve in (b)(6).The patient was doing well with the new valve.Following the explant, the old valve did not seem able to change settings when using both the handtools and stratavarius.
 
Manufacturer Narrative
The returned valve was patent.It met the requirements for valve flux, siphon, reflux, pressure-flow, and pre-implantation testing.The performance level setting was adjustable with both the handtools and the stratavarius.Therefore, the nature of the complaint could not be replicated by laboratory personnel.The valve did not pass leak testing due to a tear in the dome.It is unknown how or when the damage to the casing occurred.The ifu cautions, ¿improper use of instruments in the handling or implantation of shunt products may result in the cutting, slitting or crushing of component.Such damage may lead to loss of shunt integrity.¿ there was debris on the interior of the valve.The ifu cautions that, ¿care must be taken to ensure that particulate contaminants are not introduced into shunt components during preimplantation testing or handling.Introduction of contaminants could result in improper performance of the shunt system.Particulate matter that enters the shunt system may result in shunt occlusion or may also hold pressure/flow controlling mechanisms open, resulting in overdrainage¿.All valves are 100% tested at the time of manufacture.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATA II VALVE, REGULAR
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
MDR Report Key8201280
MDR Text Key131583332
Report Number2021898-2018-00594
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K042465
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model Number42866
Device Catalogue Number42866
Device Lot NumberE45681
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/04/2019
Initial Date Manufacturer Received 12/14/2018
Initial Date FDA Received12/27/2018
Supplement Dates Manufacturer Received01/18/2019
Supplement Dates FDA Received02/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-